U.S. private equity firm Hellman & Friedman is exploring a sale of medical devices maker Cordis, aiming for a valuation exceeding $9 billion. Several publicly traded medical device companies are reportedly considering bids. Hellman & Friedman acquired Cordis in 2021 for approximately $1 billion.